Barclays PLC Catabasis Pharmaceuticals, Inc. Transaction History

Barclays PLC

  • $377 Billion
  • Q3 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 09, 2021
SELL
N/A
-5,311 Closed
0 $0
Q2 2021

Aug 13, 2021
SELL
N/A
-31,615 Reduced 85.62%
5,311 $11,000
Q1 2021

May 13, 2021
BUY
N/A
10,392 Added 39.16%
36,926 $107,000
Q4 2020

Feb 11, 2021
BUY
N/A
17,776 Added 202.97%
26,534 $57,000
Q3 2020

Nov 12, 2020
SELL
N/A
-1,155 Reduced 11.65%
8,758 $54,000
Q2 2020

Aug 12, 2020
BUY
N/A
9,913 New
9,913 $64,000

About Catabasis Pharmaceuticals, Inc.

CATB Quotes by TradingView
  • Ticker CATB
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,948,800
  • Market Cap $657M
More about CATB
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email